ロード中...
Efficacy and Safety of a Microsomal Triglyceride Transfer Protein Inhibitor in Homozygous Familial Hypercholesterolemia
BACKGROUND: Patients with homozygous familial hypercholesterolemia (HoFH) respond inadequately to existing drugs. We conducted a phase 3 study to assess the efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in adults with HoFH. METHODS: Twenty-nine subjects enr...
保存先:
| 出版年: | Lancet |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4587657/ https://ncbi.nlm.nih.gov/pubmed/23122768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(12)61731-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|